DESCRIPTION:OZURDEX is an intravitreal implant containing 0.7 mg dexamethasone in the NOVADUR solid polymer drug delivery system. OZURDEX is preloaded into a single-use, specially designed DDS applicator to facilitate injection of the rod-shaped implant directly into the vitreous. The NOVADUR system contains poly PLGA intravitreal polymer matrix. OZURDEX is preservative-free.INDICATIONS AND USAGEOZURDEX contains a corticosteroid indicated for the treatment of macular edema following branch retinal vein occlusion BRVO or central retinal vein occlusion.DOSAGE AND ADMINISTRATION:
For ophthalmic intravitreal injection only.
The intravitreal injection procedure should be carried out under controlled aseptic conditions. Following the intravitreal injection, patients should be monitored for elevation in intraocular pressure and for endophthalmitis.